ICU acquisition rate, risk factors, and clinical significance of digestive tract colonization with extended-Spectrum Beta-lactamase–producing Enterobacteriaceae: a …

M Detsis, S Karanika, E Mylonakis - Critical care medicine, 2017 - journals.lww.com
Objective: To evaluate the acquisition rate, identify risk factors, and estimate the risk for
subsequent infection, associated with the colonization of the digestive tract with extended …

Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community

JDD Pitout, P Nordmann, KB Laupland… - Journal of …, 2005 - academic.oup.com
Enterobacteriaceae, especially Klebsiella spp. producing extended-spectrum β-lactamases
(ESBLs) such as SHV and TEM types, have been established since the 1980s as a major …

[PDF][PDF] Surveillance of extended-spectrum-ß-lactamase-producing enterobacteriaceae in a Swiss Tertiary Care Hospital

C Fankhauser, W Zingg, P François, S Dharan - Swiss medical weekly, 2009 - smw.ch
Background: Extended spectrum beta-lactamase producing enterobacteriaceae (ESBL-E)
are increasing worldwide, but there is sparse data on patient-to-patient transmission and the …

Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects

CC Sheu, SY Lin, YT Chang, CY Lee… - Expert Review of Anti …, 2018 - Taylor & Francis
Introduction: The spread of extended-spectrum β–lactamase (ESBL)-producing
Enterobacteriaceae has become a major public health threat worldwide. Area covered: A …

Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae among patients at hospital admission and of …

R Friedmann, D Raveh, E Zartzer… - Infection Control & …, 2009 - cambridge.org
Objective. To determine the rates of and risk factors for carriage and acquisition of extended-
spectrum (β-lactamase (ESBL)-producing Enterobacteriaceae during hospitalization …

Bacteraemia due to Escherichia coli producing extended-spectrum beta-lactamases (ESBL): clinical relevance and today's insights

AM García-Hernández, E Garcia-Vazquez… - Revista espanola de …, 2011 - europepmc.org
Antibiotic resistance is an old problem with new face as the rate of infections due to
multidrug resistant bacteria is higher everyday and the number of new antibiotics to …

Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations

M Thouverez, D Talon, X Bertrand - Infection Control & Hospital …, 2004 - cambridge.org
Objective: To evaluate the usefulness of screening cultures in the control of extended-
spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in intensive care units …

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli

CI Kang, JH Song, DR Chung, KR Peck, KS Ko… - International journal of …, 2010 - Elsevier
The purpose of this study was to identify risk factors for extended-spectrum β-lactamase
(ESBL)-producing Escherichia coli amongst community-onset bacteraemia and to evaluate …

The continuing plague of extended-spectrum β-lactamase producing enterbacterales infections: an update

A Adler, DE Katz, D Marchaim - Infectious Disease Clinics, 2020 - id.theclinics.com
The incidence of infections caused by multidrug-resistant (MDR) gram-negative bacilli
(GNB) pathogens, affecting humans in hospitals, outpatient health care facilities, and …

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae

A Russo, M Falcone, B Gutiérrez-Gutiérrez… - International journal of …, 2018 - Elsevier
Purpose There are few data in the literature regarding sepsis or septic shock due to
extended-spectrum β-lactamases (ESBL)-producing Enterobacteriaceae (E). The aim of this …